NEWS
Council Updates
The Jersey Biopharma Council shares updates on sector developments, engagement with government and regulators, and publications relating to the Island’s regulated biopharmaceutical industry.
Updates and announcements from the Jersey Biopharma Council will be published here as they become available.
-
Planning and infrastructure support highlighted in Jersey biopharmaceutical sector feature
A recent feature published by The Planner examined the development of Jersey’s regulated medicinal cannabis and biopharmaceutical sector, including the planning, infrastructure, and regulatory frameworks supporting industry growth. The article highlighted how Jersey has adapted elements of its rural economy strategy, licensing system, and planning environment to support the development of high-specification cultivation and production…
-
Minister backs renewed political support for Jersey biopharmaceutical sector
Recent reporting by the Jersey Evening Post highlighted renewed political support for Jersey’s regulated biopharmaceutical sector following the industry’s first profitable year. Economic Development Minister Kirsten Morel called for continued backing for the sector, describing it as a “high-value, low-footprint” industry with long-term economic potential for the Island. The report also noted the sector’s expansion…
-
Jersey’s biopharmaceutical sector records first annual profit
Recent reporting by the Jersey Evening Post highlighted that Jersey’s regulated medicinal cannabis and biopharmaceutical sector recorded its first annual profit in 2025. According to the report, the sector generated more than £12 million in sales last year, supported by continued investment, export growth, and employment across the industry. The article also highlighted growing political…